8,785 results match your criteria: "Insulinoma"
Zhongguo Zhong Yao Za Zhi
November 2024
School of Pharmaceutical Sciences, Hubei University of Medicine Shiyan 442000, China Institute of Wudang Traditional Chinese Medicine, Taihe Hospital, Hubei University of Medicine Shiyan 442000, China Department of Pharmacy, Taihe Hospital, Hubei University of Medicine Shiyan 442000, China.
This study established a pyroptosis injury model by stimulating insulinoma cells(INS-1) of rats with high glucose(HG) and observed the impact of additional ethanol(ET) exposure on cell pyroptosis, as well as the intervention effect of salidroside(SAL). INS-1 cells were cultured and divided into a normal control group(NG), an HG group, an HG + ET(100 mmol·L~(-1)) group, and an HG + ET + SAL(1-100 μmol·L~(-1)) group. After 72 hours of treatment, cell viability was assessed using the cell counting kit-8(CCK-8) assay.
View Article and Find Full Text PDFWorld J Nucl Med
December 2024
Radiation Medicine Centre, Bhabha Atomic Research Centre, Tata Memorial Hospital Annexe, Mumbai, Maharashtra, India.
Insulinoma is a relatively uncommon pancreatic neuroendocrine tumor, with approximately 10% of the cases being malignant. Diabetes mellitus (DM) with concurrent insulinoma is very rare and the diagnosis of such condition is easily missed as it can be misconstrued as improved glycemic control. Therefore, persistent hypoglycemic symptoms even after stopping antidiabetic medications may be considered for insulinoma.
View Article and Find Full Text PDFCureus
November 2024
Department of Internal Medicine, Centro Hospitalar Tondela-Viseu, Viseu, PRT.
Insulinomas are rare pancreatic neuroendocrine tumors (NETs) characterized by autonomous insulin secretion leading to hypoglycemia. Malignant insulinomas are defined by the presence of metastases and present significant therapeutic challenges due to limited treatment options. We report the case of a 69-year-old woman with a two-month history of neuroglycopenic symptoms, including morning headaches, blurred vision, palpitations, and sweating, which were alleviated by sugar intake.
View Article and Find Full Text PDFJ Appl Toxicol
January 2025
Regenerative Medicine Laboratory, Dr. D. Y. Patil Dental College and Hospital, Dr. D. Y. Patil Vidyapeeth, Pimpri, Pune, India.
In the past 2-3 decades, numerous attempts have been made to create an insulin-secreting β cell line that maintains normal insulin secretion. However, primary β cell cultures have finite life and, therefore, cannot be used for long-term experiments. The most widely used insulin-secreting cell lines are Insulinoma-1, rat insulinoma cell line, hamster pancreatic β cell line, mouse insulinoma, and β tumor cell line.
View Article and Find Full Text PDFEndocrinol Diabetes Metab Case Rep
October 2024
Department of Endocrinology, Beaumont Hospital, Dublin, Ireland.
Summary: Adrenocortical carcinoma (ACC) is a rare malignant tumour arising from the adrenal cortex, with an estimated annual incidence of one to two patients per million. Ectopic ACCs are extremely rare. The majority of ACCs are sporadic; however, ACC has been linked with genetic disease processes, including multiple endocrine neoplasia type-1 (MEN-1).
View Article and Find Full Text PDFAnimals (Basel)
November 2024
VetCorner Unavets, 50012 Zaragoza, Spain.
Int J Cancer
November 2024
OCDEM, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
Hepatobiliary Pancreat Dis Int
November 2024
Department of Academic Surgery, The Royal Marsden NHS Foundation Trust, Fulham Road, Chelsea, London SW3 6JJ, UK; Department of HPB Surgery, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol Royal Infirmary, Upper Maudlin St, Bristol BS2 8HW, UK. Electronic address:
Biochim Biophys Acta Mol Basis Dis
February 2025
Cell Signaling Laboratory, Department of Zoology, Siksha Bhavana (Institute of Science), Visva-Bharati University, Santiniketan 731235, India. Electronic address:
Biochem Biophys Res Commun
December 2024
School of Nutrition Sciences, Health Sciences, University of Ottawa, Ottawa, K1H 8M5, Canada; Department of Chemistry and Biomolecular Sciences, Science, University of Ottawa, Ottawa, Ontario, K1N 6N5, Canada; University Food Properties and Nutrient Bioavailability, University of Ottawa, Ottawa, Ontario, K1H 8M5, Canada. Electronic address:
Updates Surg
December 2024
Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Front Endocrinol (Lausanne)
November 2024
Department of Genetics and Bioinformatics, Dasman Diabetes Institute, Kuwait City, Kuwait.
Lipids Health Dis
November 2024
Department of Biochemistry, School of Medicine, Iran University of Medical Sciences, P.O. Box: 1449614535, Tehran, Iran.
Neuroendocrinology
November 2024
World-Class Research Centre for Personalized Medicine, Almazov National Medical Research Centre, Saint Petersburg, Russian Federation.
Sci Rep
November 2024
CIBER of Diabetes and Related Metabolic Disorders, Instituto de Salud Carlos III, 28040, Madrid, Spain.
Sci Rep
November 2024
Department of Biochemistry, Chungbuk National University, Cheongju, 28644, Republic of Korea.
Abdom Radiol (NY)
November 2024
State Key Laboratory of Complex Severe and Rare Diseases, Beijing, China.
Clin Case Rep
November 2024
Department of Diabetes, Metabolism, and Endocrinology International University of Health and Welfare, Narita Hospital Chiba Japan.
Clin Nucl Med
January 2025
From the Department of Nuclear Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.
Front Endocrinol (Lausanne)
November 2024
Division of Endocrinology, Department of Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Oncologist
October 2024
Department of Medicine, University of California, San Francisco, CA 94143, United States.
Diagn Pathol
October 2024
Department of Pathology, Fujian Provincial Hospital, Provincial Clinical Medical College of Fujian Medical University, Fuzhou University Affiliated Provincial Hospital, NO.134 East Street, Gulou District, Fuzhou, Fujian, 350001, P.R. China.
Diabetol Int
October 2024
Department of Diabetes, Endocrinology and Metabolism and Department of Rheumatology and Clinical Immunology, Gifu University Graduate School of Medicine, 1-1 Yanagido, Gifu, 501-1194 Japan.
JCEM Case Rep
November 2024
Department of Endocrinology, PGIMER, Chandigarh 160012, India.
J Nanobiotechnology
October 2024
Joint Research Centre on Medicine, The Affiliated Xiangshan Hospital of Wenzhou Medical University, Ningbo, Zhejiang, 315700, P. R. China.
The primary issues in treating type 1 diabetes mellitus (T1DM) through the transplantation of healthy islets or islet β-cells are graft rejection and a lack of available donors. Currently, the majority of approaches use cell encapsulation technology and transplant replacement cells that can release insulin to address transplant rejection and donor shortages. However, existing encapsulation materials merely serve as carriers for islet cell growth.
View Article and Find Full Text PDF